awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Table
SPARQL
Graphs
1
1
Services
1
1
Assets
0
0
Insights
Schema
BETA
Class frequency
Class hierarchy
Q48650575-92452AA8-7FD9-4A7A-A79C-6F889D3034F2
Q48650575-92452AA8-7FD9-4A7A-A79C-6F889D3034F2
BestRank
Statement
http://www.wikidata.org/entity/statement/Q48650575-92452AA8-7FD9-4A7A-A79C-6F889D3034F2
A longitudinal real-life comparison study of natalizumab and fingolimod.
P2860
Q48650575-92452AA8-7FD9-4A7A-A79C-6F889D3034F2
BestRank
Statement
http://www.wikidata.org/entity/statement/Q48650575-92452AA8-7FD9-4A7A-A79C-6F889D3034F2
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
e29674d20419b4b634d8611137375493cc813974
P2860
Switching therapy from natalizumab to fingolimod in relapsing-remitting multiple sclerosis: clinical and magnetic resonance imaging findings.